Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer
- PMID: 28341421
- PMCID: PMC5441954
- DOI: 10.1016/j.bbcan.2017.03.005
Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer
Abstract
The origin and progression of cancer is widely viewed as "somatic evolution" driven by the accumulation of random genetic changes. This theoretical model, however, neglects fundamental conditions for evolution by natural selection, which include competition for survival and a local environmental context. Recent observations that the mutational burden in different cancers can vary by 2 orders of magnitude and that multiple mutations, some of which are "oncogenic," are observed in normal tissue suggests these neglected Darwinian dynamics may play a critical role in modifying the evolutionary consequences of molecular events. Here we discuss evolutionary principles in normal tissue focusing on the dynamical tension between different evolutionary levels of selection. Normal somatic cells within metazoans do not ordinarily evolve because their survival and proliferation are governed by tissue signals and internal controls (e.g. telomere shortening) that maintain homeostatic function. The fitness of each cell is, thus, identical to the whole organism, which is the evolutionary level of selection. For a cell to evolve, it must acquire a self-defined fitness function so that its survival and proliferation is determined entirely by its own heritable phenotypic properties. Cells can develop independence from normal tissue control through randomly accumulating mutations that disrupt its ability to recognize or respond to all host signals. A self-defined fitness function can also be gained non-genetically when tissue control signals are lost due to injury, inflammation, or infection. Accumulating mutations in cells without a self-defined fitness function will produce no evolution - consistent with reports showing mutations, including some that would ordinarily be oncogenic, are present in cells from normal tissue. Furthermore, once evolution begins, Darwinian forces will promote mutations that increase fitness and eliminate those that do not. Thus, cancer cells will typically have a mutational burden similar to adjacent normal cells and many (perhaps most) mutations observed in cancer cells occurred prior to somatic evolution and may not contribute to the cell's malignant phenotype. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby.
Keywords: Cancer evolution somatic mutations theory; Fitness function; Somatic evolution.
Copyright © 2017 Elsevier B.V. All rights reserved.
Figures

Similar articles
-
Somatic clonal evolution: A selection-centric perspective.Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):139-150. doi: 10.1016/j.bbcan.2017.01.006. Epub 2017 Feb 2. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28161395 Review.
-
Changing mutational and adaptive landscapes and the genesis of cancer.Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):84-94. doi: 10.1016/j.bbcan.2017.01.005. Epub 2017 Feb 4. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28167050 Free PMC article. Review.
-
Tumor evolution: Linear, branching, neutral or punctuated?Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28110020 Free PMC article. Review.
-
A population genetics perspective on the determinants of intra-tumor heterogeneity.Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):109-126. doi: 10.1016/j.bbcan.2017.03.001. Epub 2017 Mar 6. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28274726 Free PMC article. Review.
-
Evolutionary scalpels for dissecting tumor ecosystems.Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):69-83. doi: 10.1016/j.bbcan.2016.11.005. Epub 2016 Dec 5. Biochim Biophys Acta Rev Cancer. 2017. PMID: 27923679 Free PMC article. Review.
Cited by
-
Special Collection on Ecological and Evolutionary Approaches to Cancer Control: Cancer Finds a Conceptual Home.Cancer Control. 2020 Jan-Dec;27(1):1073274820942356. doi: 10.1177/1073274820942356. Cancer Control. 2020. PMID: 33054362 Free PMC article.
-
Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma.Int J Mol Sci. 2022 Dec 17;23(24):16132. doi: 10.3390/ijms232416132. Int J Mol Sci. 2022. PMID: 36555771 Free PMC article.
-
Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions.Front Endocrinol (Lausanne). 2018 Jun 15;9:318. doi: 10.3389/fendo.2018.00318. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29963012 Free PMC article. Review.
-
ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.Front Oncol. 2021 Sep 9;11:731547. doi: 10.3389/fonc.2021.731547. eCollection 2021. Front Oncol. 2021. PMID: 34568067 Free PMC article.
-
Insights From the Ecology of Information to Cancer Control.Cancer Control. 2020 Jul-Aug;27(3):1073274820945980. doi: 10.1177/1073274820945980. Cancer Control. 2020. PMID: 32762341 Free PMC article.
References
-
- Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23–28. - PubMed
-
- Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. - PubMed
-
- Gerlinger M, McGranahan N, Dewhurst SM, Burrell RA, Tomlinson I, Swanton C. Cancer: evolution within a lifetime. Annu Rev Genet. 2014;48:215–236. - PubMed
-
- Vaux DL. In defense of the somatic mutation theory of cancer. Bioessays. 2011;33:341–343. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources